Filter
157
Text search:
genotypic
testing
Featured
Recommendations
25
New Publications
48
Language
Document type
No document type
93
Guidelines
31
Studies & Reports
23
Manuals
6
Strategic & Response Plan
4
Countries / Regions
India
8
Western and Central Europe
6
Ethiopia
5
Africa
4
Eastern Europe
4
Myanmar / Burma
3
Zambia
2
Kenya
2
Malawi
2
Mozambique
2
Latin America and the Carribbean
2
Asia
2
Russia
2
Estonia
2
Sierra Leone
1
Nigeria
1
Senegal
1
USA
1
Uganda
1
Philippines
1
Tanzania
1
Thailand
1
Bangladesh
1
Benin
1
North Macedonia
1
Colombia
1
Botswana
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Georgia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
39
Clinical Guidelines
30
Pharmacy & Technologies
10
Public Health
8
Capacity Building
1
Women & Child Health
1
Key Resources
1
Toolboxes
TB
51
HIV
27
AMR
14
Rapid Response
5
COVID-19
5
NTDs
5
Mental Health
3
Pharmacy
3
Polio
2
Refugee
2
Ebola
1
Natural Hazards
1
Caregiver
1
NCDs
1
Revised National Tuberculosis Control Programme
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
(updated December 2014).
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care
...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview
...
2nd edition
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha
...
Unofficial Translation
Approved by the Federal Government on October 20, 2016
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
